Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 602 49 722.1 |
96 | EP file number | EAKZ | 16 18 6041.6 |
97 | EP publication number | EPN | 3143995 |
54 | Designation/title | TI | EIN RAPAMYCINDERIVAT ZUR BEHANDLUNG VON LUNGENKREBS |
51 | IPC main class | ICM (ICMV) | A61K 31/436 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01) |
22 | DE application date | DAT | Feb 18, 2002 |
96 | EP application date | EAT | Feb 18, 2002 |
43 | Date of first publication | OT | Mar 22, 2017 |
| Date of publication of grant | PET | Dec 5, 2018 |
71/73 | Applicant/owner | INH | Novartis Pharma AG, Basel, CH |
72 | Inventor | IN | Lane, Heidi, 4106 Therwill, CH; O'Reilly, Terence, 4057 Basel, CH; Wood, Jeanette Marjorie, 4105 Biel-Benken, CH |
74 | Representative | VTR | Breuer, Markus, Dr., 80331 München, DE |
| Address for service | | Breuer, Markus, Dr., 80331 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0124957 Oct 17, 2001
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0104072 Feb 19, 2001
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2019 000 051.8 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003143995A1 Searchable text:
EP000003143995A1 Original document:
EP000003143995B1 Searchable text:
EP000003143995B1 Original document:
EP000003143995B2 Searchable text:
EP000003143995B2 |
43 | Date of first publication | EVT | Mar 22, 2017 |
| Date of the first transfer into DPMAregister | EREGT | Mar 23, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 23, 2025 (Show all update days)(Hide all update days)- Jan 23, 2025
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 15.01.2025: changed
- Dec 19, 2024
- Published EP/WO documents: changed
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 15.01.2025: new
- Procedures: Opposition procedure, Patent maintained in amended form by EPO, 15.01.2025: new
- Jul 25, 2024
- Representative: changed
- Address for service: changed
- Procedures: New representative details, New representative details, 05.09.2019: changed
- Feb 20, 2022; Nov 25, 2021; Apr 29, 2021; Feb 12, 2021; Jul 30, 2020; Jun 25, 2020; Feb 14, 2020; Sep 6, 2019; Aug 23, 2019; Aug 1, 2019; Jun 27, 2019; May 16, 2019; Apr 9, 2019; Feb 13, 2019; Dec 27, 2018; Nov 17, 2018; Nov 15, 2018; Jul 19, 2018; May 4, 2017
- Historical data not available for this/these date(s)
- Mar 23, 2017
- Date of the first transfer into DPMAregister
|